TAGIP 50MG TAB Reducid 40mg 20' New The extended-release design provides sustained

The extended-release design provides sustained medication delivery for consistent glucose management

maintain consistent application throughout the recommended treatment duration

exploring its benefits and why it remains a popular choice among caregivers

Suitable for adults requiring combination therapy when monotherapy is insufficient

TAGIP 50MG TAB Reducid 40mg 20' New The extended-release design provides sustainedTAGIP 50MG contains Sitagliptin, a dipeptidyl peptidase 4 (DPP 4) inhibitor used to help manage type 2 diabetes mellitus. It works by increasing insulin release and decreasing glucagon levels when blood sugar is high. Each tablet contains 50mg of Sitagliptin phosphate monohydrate. This medication is typically taken once daily, with or without food, as directed by your healthcare provider. TAGIP is suitable for patients seeking effective blood sugar